Radioiodinated recombinant human interferon-gamma (IFN-y) bound to human monocytes, U937, and HL60 cells in a specific, saturable, and reversible manner. At 40C, the different cell types bound 3,000-7,000 molecules of IFNy, and binding was of comparable affinity (K. = 4-12 X 10 M-l). No change in the receptor was observed after monocytes differentiated to macrophages or when the cell lines were pharmacologically induced to differentiate. The functional relevance of the receptor was validated by the demonstration that receptor occupancy correlated with induction of Fc receptors on U937. Binding studies using U937 permeabilized with digitonin showed that only 46% of the total receptor pool was expressed at the cell surface. The receptor appears to be a protein, since treatment of U937 with trypsin or pronase reduced '251-IFNy binding by 87 and 95%, respectively. At 370C, ligand was internalized, since 32% of the cell-associated IFNy became resistant to trypsin stripping. Monocytes degraded '251-IFNy into trichloroacetic acid-soluble counts at 370C but not at 40C, at an approximate rate of 5,000 molecules/cell per h. The receptor was partially characterized by SDS-polyacrylamide gel electrophoresis analysis of purified U937 membranes that had been incubated with _251-IFNy. After cross-linking, the receptor-ligand complex migrated as a broad band that displayed an M, of 104,000±18,000 at the top and 84,000±6,000 at the bottom. These results thereby define and partially characterize the IFNy receptor of human mononuclear phagocytes.
Introduction
Macrophage activation has been defined as a series of functional and biochemical modifications in macrophage populations (1) (2) (3) (4) that are induced by a T cell-derived lymphokine known as macrophage activating factor (MAF).' Previous reports from IFN, interferon; IRU, international reference units; Ka, association equilibrium constant; KIU, kallikrein inhibitory units; KPBS, DMEM with several laboratories, including our own, have shown that gammainterferon (IFNy) can activate mononuclear phagocytes and may well represent the major type of MAF produced by physiological T cell populations (reviewed in references 5 and 6).
These observations have prompted attempts to elucidate the biochemical basis for IFNy-dependent cellular responses. Recently, we demonstrated the presence of a specific receptor for IFNy on murine macrophages by its ability to bind ligand in a saturable, reversible, and specific manner (7) . We have also shown that receptor occupation is a prerequisite for induction of macrophage tumoricidal activity, Ia antigen expression, or enhancement of intracellular microbicidal activity (7, 8) , biological activities that are all characteristic of activated macrophages.
In the current communication, we wish to extend these observations to the IFN~y receptor of human mononuclear phagocytes. In addition, we report the partial physicochemical characterization of the human monocyte IFN-y receptor and describe the ultimate fate of the ligand after receptor binding.
Methods
Chemicals, media, and reagents. Media, supplements, and buffers used in these experiments were purchased or prepared as previously described (7, 9) , and were determined to contain <10 pg/ml of endotoxin using the Limulus amebocyte lysate assay (Sigma Chemical Co., St. Louis, MO). Reagents used specifically for this study were purchased from the following sources: phenylmethylsulfonyl fluoride (PMSF), leupeptin, 43-phorbol-1 2( myristate-1 3a acetate (PMA), dimethylsulfoxide (DMSO), ATP, and aprotinin were obtained from Sigma Chemical Co.; disuccinimydyl suberate (DSS), ethylene glycol-bis (succinimidyl succinate) (EGS) and dimethyl suberimidate 2 HCO (DMS) were purchased from Pierce Chemical Co., Rockford, IL. Interferons. Natural human IFNy was induced from partially purified human peripheral blood lymphocytes essentially as described by Blalock et al. (10) . Lymphocytes at 6 X 106 cells/ml in RPMI medium containing 1% fetal calf serum (FCS) were stimulated with 1 sg/ml staphylococcal enterotoxin B (SEB, Sigma Chemical Co.) for 24 h. The resulting culture supernatants were cleared of cell debris by centrifugation and filtration and stored at -20'C. This preparation had a specific activity of 1.1 specific activities of 2.1 X 10 IRU/mg for alpha interferon and I X 10' IRU/mg for beta interferon.
Preparation of radioiodinated IFN-y. Purified recombinant human IFN-y (57 Ag) was labeled with 1251I Bolton-Hunter reagent (1 mCi) (ICN Chemicals, Radioisotope Division, Irvine, CA) for 2 h at 4VC as described (7) . Protein associated and free 1251 were separated by centrifugation through Biogel P6. Typical preparations displayed specific activities of 8.3 ACi/,ug (13 11Ci/106 IRU). 125I-IFN-y was further purified by gel filtration on a high performance liquid chromatography (HPLC) system using a 7.5 x 300-mm Biosil TSK 125 column (Bio-Rad Laboratories, Richmond, CA) (7) . Fractions were collected in tubes containing '/I0 vol of heat-inactivated FCS. IFNy-specific activities were determined either with a cytopathic effect assay, which used purified vesicular stomatitis virus, human WISH cells, and the National Institutes of Health human IFNy standard, or by IFNy-specific radioimmunoassay (Centocor, Inc., Malvern, PA). Values obtained with the two assays were in close agreement. Radioiodinated IFN-y was stored at 4VC and retained biological activity for at least 2 wk.
Monoclonal antibodies. Monoclonal antibodies to recombinant human IFN-y (HGI/M6 and HGI/M 125) were produced by fusion of immune murine splenocytes with the hypoxanthine, aminoplerin, and thymidine (HAT)-sensitive murine myeloma cell line P3 X 63-Ag8.653 at a splenocyte/myeloma ratio of 10:1 using a previously described fusion protocol (8) . The resulting hybridomas were cloned three times by limiting dilution. Specificity was confirmed by enzyme-linked immunosorbent assay and radioimmunoassays that used recombinant human IFNy as antigen. In functional assays, the antibodies were found to neutralize the antiviral activity of natural human IFN-y. Purified M6 and M 125 were prepared by protein-A chromatography of clone culture supernatants.
M6 and M125 are IgG,, K, type antibodies. Monoclonal antibody 543 is specific for the human C3b receptor and was produced as described elsewhere (12) . Monoclonal anti-CR3 a-chain (OKM 10) and ,B-chain (60.3) were obtained from Ortho Diagnostics, (Raritan, NJ) and from Dr. Patrick Beatty (Fred Hutchinson Cancer Research Center, Seattle, WA), respectively. Hamster monoclonal antibodies against murine IFNy (H22) were prepared as described previously (8) .
Monocytes. Human monocytes were purified by Ficoll-Hypaque centrifugation and centrifugal elutriation. As starting material, mononuclear cell-enriched leukocyte concentrates were used that were obtained from normal donors undergoing lymphocytapheresis on a continuous flow centrifugation machine (model 2297; IBM, Princeton, NJ). 80 ml of concentrate (containing -108 leukocytes) was diluted 1:1 with sterile 0.9% sodium chloride and 4 ml layered into tubes containing 10 ml of Lymphopaque (Nyegaard and Co., Oslo, Norway). After centrifugation for 20 min at 23°C at 800 g, the mononuclear cells were collected, washed, and resuspended in 10 ml of elutriation medium (DMEM) with potassium-PBS (KPBS) containing 0.1 M NaCl, 0.002 M KCI, 0.01 M KH2PO4, 0.008 M Na2HPO4, and 250 mg/ml U. S. Pharmacopeia sterile human serum albumin (HSA) (Armour Pharmaceutical Co., Kankakel, IL) (DMEM-KPBS-HSA). The cells were injected into the loading chamber of an elutriation system (JE-6B Elutriation System, Beckman Instruments, Inc., Palo Alto, CA) and introduced into the separation chamber with 125 ml DMEM-KPBS-HSA buffer at a flow rate of 5 ml/ min and a rotor speed of 2,000 rpm. Thereafter, two 100-ml fractions were collected at flow rates of 13 and 15 ml/min, and 11 50-ml fractions were collected at flow rates of 16 (6) (7) (8) (9) (10) (11) (12) (13) were combined and collected by centrifugation at 400 g for 10 min. The resulting cell preparation contained >95% monocytes as assessed by cytocentrifugation (Cytospin 2, Shandon Instruments, Sewickley, PA) and Giemsa-peroxidase staining (13) and displayed 99% viability.
Cultured cell lines. The human monocytic cell line U937 (14) and the promyelocytic cell line HL60 (15) were maintained in RPMI supplemented with 2 mM L-glutamine, 50 U/ml penicillin, 50 ug/ml streptomycin, 1 mM sodium pyruvate, 0.075% (wt/vol) sodium bicarbonate, and 10% heat-inactivated FCS.
Membrane preparations. U937 cells were lysed by nitrogen cavitation and the plasma membranes purified in sucrose gradients using a modification of the method described by Jesaitis et al. (16, 17) . Briefly, U937 cells (2 X 109) were washed and then suspended in 20 ml of homogenization buffer (10 mM Hepes, 0.34 M sucrose, 0.1 mM MgCl2, 10 mM EDTA, 1 mM dithiothreitol, 250 mM ATP, and 23 kallikrein inhibitory units (KIU)/ml aprotinin) in a 50-ml polyethylene tube containing a cylindrical stir bar. The cell mixture was placed in a Parr cell disruption bomb (Parr Instruments, Moline, IL) that had been precooled to 0C. The stirred cell mixture was equilibrated for 15 min at 600 psi N2 at 0C. After cavitation, 90% of the starting volume was recovered and the lysate was immediately centrifuged at 1,000 g for 5 min. The foam residue, which floated on top of the supernatant from this centrifugation, was collected and homogenized with buffer in a Dounce homogenizer and combined with the first low-speed supernatant. The mixture was centrifuged again for 5 min at 1,000 g. The supernatant of the second centrifugation was collected and layered into tubes containing sucrose gradients prepared with Hepes buffer. The gradients consisted of a 3-ml cushion of 60% sucrose and a 22-ml linear gradient ranging from 55 to 20% sucrose. The samples were centrifuged in a Sorval TV 850 vertical rotor (DuPont Co., Newton, CT) at 45,000 rpm (163,000 g) for 1 h at 40C, and 1.5-ml fractions were collected. Fractions were frozen in liquid nitrogen and stored at -80'C. In some experiments, U937 were surface labeled using '25I-wheat germ agglutinin (WGA) according to the procedure described by Jesaitis et al. (17) .
Binding studies with '25I-recombinant IFNy. The method used to quantitate cellular binding of IFN-y has been described in detail elsewhere (7) . In IFNIy in 1 ml of medium. After various lengths of time at 37°C, the culture supernatants containing unbound or degraded 125IIFNy were collected. The supernatants were mixed with 500 Ml of FCS and I ml 20% TCA at 4°C and TCA soluble and insoluble material separated by centrifugation at 4°C for 20 min at 2,000 g. Monocytes were washed at 4°C, solubilized with 1% NP40, and counted for the determination of total cell-associated radioactivity. As a control, '25IIFNly was incubated at 37°C in empty wells, then processed as above. The control levels of TCA soluble counts were subtracted as background from all data points.
An increase in TCA-soluble '25I-IFN-y in the absence of cells was never observed.
Cross-linking ofmembrane components to '25I-IFNy and SDS-polyacrylamide gel electrophoresis (PAGE) analysis. 200 Mg of membrane protein corresponding to -5 X 107 U937 were incubated with 160 ng 125IIFNJy for 2 h at 4°C. In parallel, a control tube was incubated with a 100-fold excess of unlabeled IFN-y. Membranes were washed by centrifugation in an airfuge (Beckman Instruments Inc.) for 30 min at 25 psi (120,000 g). Pelleted membranes were resuspended in 45 Ml of PBS, pH 7.3, and 5 Ml was added ofa 10-mM solution of selected cross-linking agents (DMS, DSS, or EGS) dissolved in DMSO. After incubation for 20 min at 4°C, 100 Ml of 20 mM Tris HCI, pH 7.3, was added and the membranes were washed again and resuspended in 50 Ml of 1% NP40. After 30 min at 4°C, 50 Ml SDS sample buffer was added and membranes were fractionated by SDS-PAGE using 4-12% polyacrylamide gradient slab gels as described by Laemmli (25) . The U937 (26, 27) . Fig. 4 depicts the dose-response profile for Fc receptor induction by purified human recombinant IFNy. 50% maximal induction was produced by 3 ng of IFN'y (60 IRU) and maximal stimulation occurred at 50 ng input (1,000 IRU). When the data from the above experiment and the receptor binding experiments were normalized to similar cell densities (Fig. 4, inset) , the concentration of IFN-y required for cell binding was found to correlate with that needed to induce the cellular response.
Ontogeny ofthe IFN'y receptor on mononuclear phagocytes. The ability to differentiate U937, HL60, and peripheral blood monocytes in vitro provided a mechanism to study the ontogeny of the IFNy receptor. Saponin and digitonin have been used by others to permeabilize cells, and allow quantitation of intracellular (or cryptic) and extracellular receptors ( 18, 19) . In order to obtain these values Receptor-mediated internalization of IFN-y. Whereas the binding of IFNy to U937 was homogeneous at 4°C, it was bimodal at 37°C (Fig. 7, left) . The lower affinity binding at 37°C (1.7 X l09 M-') was of similar magnitude to that observed at 40C (3.0 X 109 M-1). In addition, a high affinity binding of IFNy to the cells was observed at the elevated temperature (2.3 X 1010 M-').
The high affinity binding observed at 37°C appeared to be a result of ligand internalization and not expression of different classes of receptors. This conclusion was reached because (a) purified U937 membranes bound IFNy with a single affinity at either 4°C (1.2 X l09 M-') or 370C (i.5 X l09 M-') ( (Table III) . In this last study, monocytes bound 33% more ligand at 370C than at 4°C. When monocytes that had bound IFN-y at 40C were stripped of surface receptors by trypsin treatment, the number of cell-associated IFN-y molecules decreased from 5,300 to 700/cell. In contrast to this result, cells that had been exposed to ligand at 370C maintained 2,300 molecules of '25I-IFNy/cell Finally, 1% NP40 was added, cells were lysed, and the radioactivity associated with the cells counted.
over the 4-h period (Fig. 8) . However, TCA soluble radioactivity became detectable in culture supernatants of monocytes held at 370C for 2 h and increased linearly for the next 2 h. Based on the specific activity ofthe radioiodinated IFNy, degradation was estimated to occur at a rate of 5,000 molecules/cell per h. Characterization ofthe human monocyte IFNy receptor by SDS-PAGE. The data presented thus far defined the IFN'y receptor of human mononuclear phagocytes by classical biochemical and functional criteria. We also wished to chemically define the receptor molecule. Initial attempts to directly radioiodinate the receptor on whole U937 cells and affinity purify it on IFNycoated beads were unsuccessful probably due to the limited number of receptor molecules expressed at. the plasma membrane. However, since highly purified, radiolabeled ligand was available, we directed our efforts at affinity labeling the receptor by chemically cross-linking it to specifically bound '25I-IFN. In preliminary experiments, cross-linking was confirmed by were prelabeled with 1251WGA subjected to N2 cavitation, and purified by sucrose density gradient cen~trifugation for 1 h at 163,000 g. The distribution of 1251 WGA, protein, and sucrose is shown as a function of the relative volume collected from the sucrose density gradient. demonstrating a reduction in the dissociation rate of ligand from the cell surface (data not shown).
In order to minimize the possibility of proteolysis of the ligand-receptor complex (and reduce nonspecific labeling), plasma membrane-enriched fractions were prepared from U937 cells by N2 cavitation and subsequent isopyknic sucrose density gradient sedimentation of the homogenate as outlined in the methods section. Plasma membrane recovery was determined by the presence of '252-WGA, which had been used in trace amounts to surface label the cells. 94% ofthe radioactivity applied to the gradients was sedimentable (total recovery was 95%) and recovered as a single band with a peak at a density of 1.286 g/ c-m (30% wt/vol sucrose) (Fig. 9) . This fraction carried 23% of the total 1251-WGA and only 5.6% ofthe total protein. Thereafter, the same fraction from gradients of unlabeled membranes was used as the membrane source.
Membrane preparations were incubated with '25fIrFomU cross-linked, solubilized, and then analyzed by SDS-PAGE under reducing conditions. Fig. 10 Receptor expression and avidity were not influenced by cellular differentiation or activation, and even uncommitted precursor cells (such as HL60) carried IFN'y receptors on their surface. This observation is compatible with the previously reported ability of IFNy to induce differentiation of precursor cells such as HL60 and U937 (29, 30) , activate a variety of functions in mature human monocytes and macrophages (6) , and cause terminal differentiation of monocytes to polykarions (31). Thus, the IFNy receptor appears to be a ubiquitous component of the mononuclear phagocyte plasma membrane. This conclusion distinguishes the IFNy receptor from Fc and C3 receptors, since the latter are expressed only on more differentiated forms of mononuclear phagocytes (21, 32) .
The low magnitude of receptor expression on monocytes necessitated an indirect analysis approach to study the molecular weight ofthe receptor. Cross-linked preparations ofradiolabeled ligand and purified plasma membranes migrated on SDS-PAGE as a wide band that spanned a molecular weight range of 87,000-104,000. While this apparent heterogeneity may reflect a high level of receptor glycosylation, it is more likely that it results from the formation of a cross-linked complex between the membrane component and either the internally cross-linked whole IFNy molecule (consisting of two identical 17,000-mol wt polypeptide chains) or a single polypeptide chain subunit. Under the dissociating conditions used in the SDS-PAGE analysis, the complexes would therefore contain either a 34,000-or 1 7,000-Mr ligand component. By subtracting these values from the apparent molecular weights at the top and bottom of the band, the molecular weight of the receptor is estimated to be 70,000. The similarity of the molecular weight estimates made on different purified membrane preparations and whole cells suggests that receptor degradation did not occur during processing. However, the final assignment of a molecular weight for the IFNy receptor on mononuclear phagocytes must await an analysis of the free molecule after documentation of its ligand binding capability. Attempts are currently being made in our laboratory to achieve these goals.
Interferon-y induces a wide spectrum of biological activities in macrophages, including the induction of major histocompatibility complex class II antigens, Fc and C3bi receptors, cytocidal activity, and stimulation of ILI production (6) period. This data is consistent with our previous report (7) , which showed a similar pattern of IFNy absorption by murine mac-rophages. It is clear from these calculations that additional receptors must be recruited to the cell surface during the course of incubation. These may be derived from (a) a preexisting intracellular pool ofreceptors, (b) recycling ofinternalized receptors after the dissociation of bound ligand, or (c) de novo synthesis of additional IFN'y receptors. Increased receptor synthesis does not appear to be required, since cells treated with cycloheximide (a protein synthesis inhibitor) bound and degraded IFNy in a normal fashion (data not shown). Experiments using permeabilized cells demonstrated the presence of cryptic receptors equal in the number to the receptors at the cell surface. In studies to be presented elsewhere, receptor recycling was evidenced by the ability of lysosomotropic agents to inhibit degradation (Celada, A., and R. D. Schreiber, manuscript in preparation). It is of interest to note that murine macrophages must be kept in contact with IFN'y for at least 4 h before tumoricidal activity can be initiated (7, (34) (35) (36) . Similar observations have been reported for IFNy-dependent induction ofantiviral activity in fibroblasts (37) . The possibility thus exists that ligand internalization may play a role in inducing certain cellular responses. However, other less complex functions, such as increased hydrogen peroxide production, appear to occur as a direct consequence of ligand-receptor interaction (33) . Together, these results indicate that induction of complex biological functions in macrophages may require more than receptor-mediated signal transduction.
To date, an IFNy receptor has been detected on several different human cell types, including fibroblasts (38-41), lymphoblastoid cells (42) , epitheloid cells (43) , and, in preliminary reports, U937 (44) and monocytes (45) . At 
